Pharmacokinetics and safety of Enasidenib following single oral doses in Japanese and Caucasian subjects. (Record no. 29003120)

MARC details
000 -LEADER
fixed length control field 01466 a2200433 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518004825.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201902s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2052-1707
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1002/prp2.436
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Li, Yan
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20190204
245 00 - TITLE STATEMENT
Title Pharmacokinetics and safety of Enasidenib following single oral doses in Japanese and Caucasian subjects.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Pharmacology research & perspectives
Date of publication, distribution, etc. 12 2018
300 ## - PHYSICAL DESCRIPTION
Extent e00436 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase I; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aminopyridines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Area Under Curve
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Asian People
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Healthy Volunteers
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Isocitrate Dehydrogenase
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Triazines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element White People
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Young Adult
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Liu, Liangang
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gomez, Diana
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chen, Jian
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tong, Zeen
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Palmisano, Maria
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zhou, Simon
773 0# - HOST ITEM ENTRY
Title Pharmacology research & perspectives
Related parts vol. 6
-- no. 6
-- p. e00436
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1002/prp2.436">https://doi.org/10.1002/prp2.436</a>
Public note Available from publisher's website

No items available.